FDA Inspection
Optum Compounding Services, LLCOptum Compounding Services, LLC – FDA Inspection, Aug 13, 2021
Record Details
This FDA Inspection record concerns Optum Compounding Services, LLC, with an inspection on August 13, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- August 13, 2021
- Product Type
- Drugs
View Company Profile
ID · 7d655af9-ae0c-49e1-b75c-8cb9be64a770
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1148980
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.94(a)Reactive/Additive/Absorptive Containers/Closures
- 21 CFR 211.22(c)Approve or reject procedures or specs
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Optum Compounding Services, LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 20, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 24, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Optum Compounding Services, LLC
- FDA Inspection 1048973 - 2018-04-20
- FDA Inspection 1013242 - 2017-04-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.